Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.

Standard

Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. / Reimer, Jens; Schulte, Bernd; Castells, Xavier; Schäfer, Ingo; Polywka, Susanne; Hedrich, Dagmar; Wiessing, Lucas; Haasen, Christian; Backmund, Markus; Krausz, Michael.

in: CLIN INFECT DIS, Jahrgang 40, Nr. 5, 5, 2005, S. 373-378.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{42aa783d278047c9a130eb57b77de735,
title = "Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.",
abstract = "Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelines for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUs) in the European Union (EU) countries as a component of treatment access. National and international databases, expert contacts, professional societies, and health administrations were approached to acquire guidelines. According to their quality standard, guidelines were divided into expert opinions, semiofficial guidelines, official guidelines, and consensus processes. Recommendations for the treatment of HCV infection in IDUs vary substantially, from lack of recommendations and outright treatment disapproval to recommendations for treatment under specified circumstances. Recent guidelines that apply qualified process procedures that include literature research tend to be more permissive. Qualified guideline processes in each EU country and subsequently renewed pan-European guidelines are needed.",
author = "Jens Reimer and Bernd Schulte and Xavier Castells and Ingo Sch{\"a}fer and Susanne Polywka and Dagmar Hedrich and Lucas Wiessing and Christian Haasen and Markus Backmund and Michael Krausz",
year = "2005",
language = "Deutsch",
volume = "40",
pages = "373--378",
journal = "CLIN INFECT DIS",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

RIS

TY - JOUR

T1 - Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.

AU - Reimer, Jens

AU - Schulte, Bernd

AU - Castells, Xavier

AU - Schäfer, Ingo

AU - Polywka, Susanne

AU - Hedrich, Dagmar

AU - Wiessing, Lucas

AU - Haasen, Christian

AU - Backmund, Markus

AU - Krausz, Michael

PY - 2005

Y1 - 2005

N2 - Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelines for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUs) in the European Union (EU) countries as a component of treatment access. National and international databases, expert contacts, professional societies, and health administrations were approached to acquire guidelines. According to their quality standard, guidelines were divided into expert opinions, semiofficial guidelines, official guidelines, and consensus processes. Recommendations for the treatment of HCV infection in IDUs vary substantially, from lack of recommendations and outright treatment disapproval to recommendations for treatment under specified circumstances. Recent guidelines that apply qualified process procedures that include literature research tend to be more permissive. Qualified guideline processes in each EU country and subsequently renewed pan-European guidelines are needed.

AB - Treatment guidelines are considered to be an important tool in steering patients to medical treatment. This study was conducted to analyze guidelines for the treatment of hepatitis C virus (HCV) infection in injection drug users (IDUs) in the European Union (EU) countries as a component of treatment access. National and international databases, expert contacts, professional societies, and health administrations were approached to acquire guidelines. According to their quality standard, guidelines were divided into expert opinions, semiofficial guidelines, official guidelines, and consensus processes. Recommendations for the treatment of HCV infection in IDUs vary substantially, from lack of recommendations and outright treatment disapproval to recommendations for treatment under specified circumstances. Recent guidelines that apply qualified process procedures that include literature research tend to be more permissive. Qualified guideline processes in each EU country and subsequently renewed pan-European guidelines are needed.

M3 - SCORING: Zeitschriftenaufsatz

VL - 40

SP - 373

EP - 378

JO - CLIN INFECT DIS

JF - CLIN INFECT DIS

SN - 1058-4838

IS - 5

M1 - 5

ER -